Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-072095

Director acquired 18,450 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ebeling Thomas Director 2024-06-10 Option exercise +18,450 $13.00 $239,850 186,653 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ebeling Thomas Director 2024-06-10 Option exercise · Stock Option (Right to Buy) −18,450 0 D: show line 2 in the form
Loading xslF345X05/ownership.xml…